Wall Street Signals: Recent Legislative Victories Push CBD Into Mainstream Markets

Recent Legislative Victories Push CBD Into Mainstream Markets

Over the years, government health agencies have approved thousands of different drugs to treat a variety of conditions while hundreds of illegal drugs circulated the globe. International agencies and local governments alike tried to stamp out the plethora of drugs and had included cannabis in the widespread prohibition. However, that decision has now turned out to have been premature, as the cannabis plant has recently become a global phenomenon thanks to its therapeutic effects. Researchers have since shown that cannabis can treat certain medical conditions which include chronic pain, cancer, Alzheimer's, Parkinson's, depression, anxiety, and even depression. To date, a handful of countries have already fully legalized medical cannabis while others remain countries hesitant on approving cannabis as a medicine even though the plant's derivative, CBD or cannabidiol, is generally more accepted. CBD does not offer consumers psychoactive effect like its counterpart, marijuana, as the derivative's chemical structure has certain differences. As more research adds credibility, CBD continues to have a profound impact on the North American region, in large part because of the U.S. and Canada. For example, the U.S. has already approved a CBD-based drug, Epidiolex, to be used to treat epilepsy among children. Furthermore, the U.S. had also passed the U.S. Farm Bill in late 2018, essentially legalizing CBD throughout the nation. Canada then moved to legalize cannabis entirely in 2018 and has continued its growth since. Although cannabis is legal, Canada's government has imposed strict regulations on how many licenses are provided and how the operations of cannabis companies are handled. Even while the cannabis industry is still rapidly growing, the CBD marketspace has stood out: according to data compiled by Brightfield Group, the U.S. CBD market is expected to reach USD 22 Billion by 2022. AREV Brands International Ltd. (CSE: AREV), The Supreme Cannabis Company Inc. (OTC: SPRWF) (TSX: FIRE), Auxly Cannabis Group Inc. (OTC: CBWTF) (TSX-V: XLY), Choom Hldgs Inc. (OTC: CHOOF) (CSE: CHOO), Cannamerica Brands Corporation (OTC: CNNXF) (CSE: CANA). 
CBD has many versatile uses besides its medical applications. Consumers within the health and wellness and even beauty industry are increasingly becoming aware of CBD and its benefits. For instance, within the health and wellness marketplace, consumers can find CBD-based creams which treat skin conditions. Furthermore, CBD also comes in other forms such as flower, oils, and tinctures to satisfy a variety of consumer's demands. As the CBD industry continues to grow, new products like beverages and foods can also be seen emerging. "A few years ago almost no one knew what hemp-derived CBD was, it was sold by mostly small brands of tinctures online and through head shops. All of a sudden, CBD is everywhere - it is both a trendy, new ingredient in drinks, face creams and pet treats and an answer to the prayers of so many people suffering from medical conditions ranging from epilepsy to anxiety and chronic pain. It rides the waves of so many global food and health trends, as a substitute for opioids, towards more natural health alternatives and functional ingredients," said Bethany Gomez, Managing Director at Brightfield Group.
AREV Brands International Ltd. (CSE: AREV) is currently listed on the Canadian Securities Exchange under the ticker (CSE: AREV). Yesterday, the Company announced that it, "has worked closely with Silvertree Investments of Los Angeles, California over the past year. "Silvertree" has been actively researching, identifying and developing a strategy for AREV Brands USA Inc. to enter into the California market. A process that has involved very extensive due diligence and networking.
This lengthy process has resulted in Silvertree identifying and commencing negotiations with principle license holders in Los AngelesKing CityLong Beach, California City, San Diego, and Pasadena. The mandate is to enter into 50/50 partnerships with the license holders who will continue to operate and join our network of licenses in the State.
This plan would create a select group of license holders that link with each other to form the largest alliance and network of cultivation, processing, manufacturing, and distribution organization south of San Francisco in the State of California.
The combined license holders would gain access to the inside (two) cover pages in High Times Magazine and access to the seed vault owned by BC Bud Depot, a wholly owned asset of AREV. The High Times ad space drives traffic and customers to the BC Bud Depot website which in turn will direct orders to the licensed partner in the customer's county that the license holder serves.
BC Bud Depot supplies the genetics to the partners which ensure consumers receive quality products from a trusted and reliable source. AREV will work with the license holders of extraction licenses and Alternative Extracts Inc. to bring proprietary extraction to the network.
The company has issued 800,000 shares to settle $200,000.00 in debt with Silvertree. These costs were incurred in the normal course of business associated with the consulting work discussed above. The company also announces it has settled $32,326.88 in debt with 0991843 BC LTD. by the issuance of 129,307 shares all shares for debt are being issued at $0.25. This issuance is for the acquisition of two-piece encapsulation equipment, a 1000 liter ribbon blender, and a tea bag machine. This equipment is in addition to the recently acquired softgel system the company owns and compliments the production equipment to be installed in the Sorrento processing facility due to be completed by the fall of 2019.
Mike Withrow, CEO stated, "We continue to methodically build on our strategy of providing the Cannabis industry with superior genetics, extraction, and formulations that are produced and sold via licensing partnerships on an International platform. To accomplish this, we are only working with seasoned professionals in the Cannabis industry. We are also very carefully managing our capital and share structure when deals are being structured."
About AREV Brands International Ltd.: AREV Brands International Ltd. ("AREV") produces and delivers functional compounds and ingredients from its extraction systems. AREV is revolutionizing the current delivery method of terpenes, cannabinoids, and flavonoids. These premium ingredients and formulations are used in products targeted for sale in the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical markets. AREV innovates through extraction to produce extracts from the specifically selected plant and exude from trees that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido."
For our latest "Buzz on the Street" Show featuring AREV Brands International Ltd. recent corporate news, please head over to https://www.youtube.com/watch?v=Dr1lrNlLfYs
The Supreme Cannabis Company Inc. (OTCQX: SPRWF) (TSX: FIRE) is a Canadian publicly traded company committed to providing premium brands and products that proudly reflect its consumers, people, and uniquely innovative culture. The Supreme Cannabis Company, Inc. recently announced that its wholly-owned subsidiary, 7ACRES, had obtained Health Canada approval for six additional flowering rooms totaling 60,000 sq. ft. of additional production space at its facility in Kincardine, Ontario. Total flowering room space at 7ACRES increases from 120,000 sq. ft. to 180,000 sq. ft. and 7ACRES' annual production capacity estimate increases from approximately 17,500kg to 26,250kg. As noted in previous communications, Supreme Cannabis expects that with further production efficiencies following the licensing of all 25 flowering rooms, 7ACRES' potential capacity is anticipated to reach approximately 50,000kg per year by mid-2019. "Today's announcement is a major milestone which represents a 50% increase in our estimated annual production capacity. With 18 of 25 flowering rooms at 7ACRES now approved by Health Canada, production space at our facility is near the finish line," said John Fowler, President, and Founder of Supreme Cannabis. "With our multi-award winning 7ACRES brand now available in 8 out of 10 provinces, we look forward to completing construction of the facility so that cannabis enthusiasts coast-to-coast will be able to enjoy what we believe to be the highest-quality cannabis grown at scale in the country."
Auxly Cannabis Group Inc. (OTCQX: CBWTF) (TSX-V: XLY) is a vertically coordinated cannabis organization with assorted activities crosswise over Canada and Uruguay and a stage spreading over the whole cannabis esteem chain. Auxly Cannabis Group Inc. as of late declared that its completely possessed backup, Robinsons Cannabis Inc., had been conceded standard development and preparing licenses by Health Canada in accordance with the Cannabis Act and Cannabis Regulations. The licenses enable Robinsons to start development at its completely built 27,700 sq. ft. office in Kentville, Nova Scotia, which was reason worked to deliver brilliant cannabis. Driven by experienced head producer Andrew Robinson, Robinsons is extraordinarily situated to catch the consideration of extravagance cannabis customers, with activities based on a dedication to solid quality and excellent cannabis experience. Robinsons items have reliably positioned the most elevated regarding cannabinoid content, terpene substance and by and large, quality when freely tried against 5,000 items provided by different producers authorized as per Canadian cannabis guidelines. Hugo Alves, President of Auxly stated: "This is a major achievement for one of our key backups and individual from the Auxly family. We realize that Andrew and his group are going to create probably the best cannabis bloom accessible in Canada and we can hardly wait to impart it to Canadian shoppers. Robinsons is around an unfaltering duty to quality. We want to indicate cannabis experts, who to date have been commonly disillusioned with the blossom contributions in the market, that enthusiastic craftsman working in the managed business can create an amazing item that mirrors their pride and craftsmanship."
Choom Hldgs Inc. (OTCQB: CHOOF) (CSE: CHOO) is an emerging adult use cannabis company whose mission is to establish one of the largest retail networks in Canada and the United States. Choom Holdings Inc. recently announced that it had signed a memorandum of understanding with Better Choice Company, Inc. for the exclusive Canadian distribution rights to Better Choice's cannabidiol Bona Vida brand of products targeted for animal health and wellness once approved for sale in Canada. The terms of the MOU are not material. Under its Bona Vida brand, Better Choice offers a suite of CBD pet-focused products in the form of oils and soft chews with several formulations designed to aid the state of good health and well-being in pets. Bona Vida has formulations which specifically target animals Relaxation & Heart Support, Muscle & Joint, as well as, Skin & Body. "We are excited that Better Choice has chosen us as their exclusive distributor in Canada for their pet-focused CBD products," stated Chris Bogart, President and Chief Executive Officer of Choom. "We recognize the importance of growing our brand portfolio and having the sole distribution rights for Better Choice products helps us achieve that in an entirely new market on the horizon in pet use products. From what we know of in the United States, the CBD products for pet use market has proven to be a high margin business. As the normalization of cannabis-based products in Canada grows, consumers will begin to shift towards these new natural alternative treatments for their pets."
Cannamerica Brands Corporation (OTCQB: CNNXF) (CSE: CANA) is a U.S. marine veteran founded and operated a portfolio of cannabis brands with licensing agreements in the states of ColoradoNevada, and Maryland. The Company recently announced that it had entered into a binding letter of intent to create a joint venture with Sericea Labs S.A. de C.V. and CBDistribution Company Ltd. with the intention of building a facility in Mexico for importing and warehousing licensed CBD products as well as CBD oils and tinctures destined for refining. When and if permitted under Mexican laws, the Company, SERICEA, and CBDC also plan on acquiring, importing and cultivating industrial hemp biomass for extraction into CBD isolate to be used for multiple product lines which utilize CBD. "We are very pleased to enter the Latin American region with our partners in Mexico. This marks an exciting step for our brand's expansion in the international CBD marketplace," said Dan Anglin, Chief Executive Officer and Co-Founder of CannAmerica. "Coupled with our partnership in Europe, the global distribution of CannAmerica products is our key focus in 2019."  
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia 
Follow us on Twitter for real-time Financial News Updates: https://twitter.com/financialbuzz 
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz 
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com 
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production, and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media, and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For arev brands international ltd. financial and corporate news dissemination, FinancialBuzz.com has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure, and Terms of Use, please visit http://www.financialbuzz.com.
For further information: 
Media Contact: info@financialbuzz.com 
Url: www.FinancialBuzz.com
SOURCE FinancialBuzz.com